COCO-SCALP coal tar solution 12% w/w, salicylic acid 2% w/w and sulfur-precipitated 4% w/w ointment tube Australia - English - Department of Health (Therapeutic Goods Administration)

coco-scalp coal tar solution 12% w/w, salicylic acid 2% w/w and sulfur-precipitated 4% w/w ointment tube

aft pharmaceuticals pty ltd - coal tar solution, quantity: 12 % w/w; precipitated sulfur, quantity: 4 % w/w; salicylic acid, quantity: 2 % w/w - ointment - excipient ingredients: peg-20 glyceryl stearate; white soft paraffin; liquid paraffin; glycerol; cetostearyl alcohol; coconut oil; hard paraffin - coco-scalp is for the treatment of dry scaly skin disorders of the scalp such as psoriasis, seborrhoiec dermatitis, eczema and dandruff

Coal tar solution 12.5% / Salicylic acid 2% / Sulfur 2% ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

coal tar solution 12.5% / salicylic acid 2% / sulfur 2% ointment

special order - coal tar solution; salicylic acid; sulfur - cutaneous ointment - 125mg/1gram ; 20mg/1gram ; 20mg/1gram

Coal tar solution strong 10% / Salicylic acid 2% in Unguentum M cream United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

coal tar solution strong 10% / salicylic acid 2% in unguentum m cream

special order - salicylic acid; coal tar solution strong - cutaneous cream - 20mg/1gram ; 100mg/1gram

Cocois ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cocois ointment

rph pharmaceuticals ab - coal tar solution; sulfur precipitated; salicylic acid - cutaneous ointment - 120mg/1gram ; 40mg/1gram ; 20mg/1gram

Cocois ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cocois ointment

sigma pharmaceuticals plc - coal tar solution; sulfur precipitated; salicylic acid - cutaneous ointment - 120mg/1gram ; 40mg/1gram ; 20mg/1gram

Cocois ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cocois ointment

mawdsley-brooks & company ltd - coal tar solution; sulfur precipitated; salicylic acid - cutaneous ointment - 120mg/1gram ; 40mg/1gram ; 20mg/1gram

Cocois ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cocois ointment

de pharmaceuticals - coal tar solution; sulfur precipitated; salicylic acid - cutaneous ointment - 120mg/1gram ; 40mg/1gram ; 20mg/1gram

Cocois ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cocois ointment

waymade healthcare plc - sulfur precipitated; coal tar solution; salicylic acid - cutaneous ointment - 40mg/1gram ; 120mg/1gram ; 20mg/1gram

Coco-Scalp New Zealand - English - Medsafe (Medicines Safety Authority)

coco-scalp

aft pharmaceuticals ltd - coal tar solution 12%{relative};  ;  ; salicylic acid 2%{relative};  ; sulfur 4%{relative};   - topical ointment - 12%w/w, 2%w/w, 4%w/w - active: coal tar solution 12%{relative}     salicylic acid 2%{relative}   sulfur 4%{relative}   excipient: cetostearyl alcohol coconut oil glycerol hard paraffin liquid paraffin macrogol stearate 400 white soft paraffin

Clopidogrel/Acetylsalicylic acid Teva European Union - English - EMA (European Medicines Agency)

clopidogrel/acetylsalicylic acid teva

teva pharma b.v. - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - combinations - clopidogrel/acetylsalicylic acid teva is indicated for the prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa). clopidogrel/acetylsalicylic acid teva is a fixed‑dose combination medicinal product for continuation of therapy in:non‑st segment elevation acute coronary syndrome (unstable angina or non‑q‑wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy